The DNA fragment containing the acrA locus of the Escherichia coli chromosome has been cloned by using a complementation test (4, 24 
proteins are discussed.
The global level of DNA supercoiling in Escherichia coli is controlled by a competition between two complementary enzymes, topoisomerase I and DNA gyrase. The division of labor between topoisomerase I and gyrase is evident at the biochemical level, since topoisomerase I removes only negative supercoils under physiological conditions (14) whereas gyrase can relax positive supercoils or introduce negative supercoils (8) . It appears that topoisomerase I and gyrase compoise a homeostatic system for maintaining DNA supercoiling near an optimal set point in vivo (4, 24) .
Some of the earliest evidence that topoisomerase I and gyrase work together as a homeostatic system came from genetic studies on the effects of deletions of the gene for topoisomerase I in E. coli (5) . Deletion of topA is deleterious to E. coli, and AtopA mutants readily acquire compensatory mutations at other loci. A number of the compensatory mutations were mapped to gyrA or gyrB, and they reduced the level of gyrase activity in the cell (5, 37) . Not all compensatory mutations mapped to the genes for gyrase, however. One class of compensatory mutations occurred near tolC at 66 min on the genetic map (38) .
Mutations at the acrA locus also occurred in response to deletion of topA (5) . These mutations were not truly compensatory, since by themselves they did not restore viability to AtopA transductants (5) . However, under specific growth conditions, others have found that acrA lesions are compensatory for deletion of topA. Dorman et al. (6) showed that AtopA could be transduced directly into an acrA mutant background when cells are grown in a low-osmolarity medium. Nothing is known about why acrA mutations follow deletion of topA or how these acrA mutants permit loss of topA during growth in a low-osmolarity medium. Gene acrA, which maps between proC and purE at 10.5 min on the E. coli chromosome, was first identified because Subsequent studies showed that mutations at the same locus also determined susceptibility to other basic dyes, detergents, and certain antibiotics (3, 28) . Thus, acrA was originally thought to contribute to the integrity of E. coli membranes. Nakamura and Suganuma (30) first suggested that acrA mutations affected the biosynthesis of a 58-kDa inner membrane protein and that more acriflavine was bound to the inner membrane in an acrA mutant. However, this model does not easily explain the hypersusceptibility of acrA mutants toward a broad spectrum of other drugs. It is also not consistent with the hypothesis that it is the outer membrane, not the inner membrane, that constitutes the major barrier for most drugs (35) . Coleman and Leive (3) did not detect any change in composition of inner or outer membrane proteins in an acrA mutant. Instead, they observed a 50% reduction in the phosphate content of the lipopolysaccharides, but these data were later retracted (18) . To date, no defects in membrane structure have been unambiguously shown to be associated with mutations of acrA, and the basis for drug hypersusceptibility in acrA mutants remains an enigma.
Here we report the molecular cloning of genes at the acrA locus by complementation of the drug hypersusceptibility in one acrA mutant, N43. Sequence analysis identified two open reading frames (ORFs) at the previously assigned acrA locus. In N43, an IS2 insertion was found in the upstream ORF, which has been designated acrA. The downstream ORF has been designated acrE. Hydropathy plots and Tn,phoA fusions have been used to analyze the topologies of AcrA and AcrE. Moreover, AcrA and AcrE are highly homologous at the amino acid level to EnvC and EnvD, respectively. The effects of mutations on drug susceptibility at these loci have also been compared. Finally, the potential functions of these proteins and the possible mechanisms by which acrA mutations alleviate the deleterious effects of topA deletion are discussed. 
MATERIALS AND METHODS
Bacteria strains and growth conditions. Strains used for cloning the acrA locus and determining drug susceptibility due to mutation at the acrAE loci were W4573 (F-K-12 lac ara mal xyl mtl gal rpsL) and its isogenic acrA mutant derivative N43 (W4573 acrAl). Drug susceptibility due to mutation at the envCD loci was assayed by using P678SR [thr-I ara-13 leuB6 tonA2 lacYl supE44? gal-6 X-rpsLl35 malAl(Xr) xyl-7 thi-I mtl-2] and PM61 [thr-I ara-13 leuB6 tonA2 lacYl supE44 gal-6 X-rpsL135 malAl(Xr) xyl-7 thi-1 envC61]. TnphoA fusion constructs were assayed in strain CC118 [araD139 A(ara, leu)7697 AlacX74 phoAA20 galE galK thi rpsE rpoB argE(Am) recAl]. LB medium (10 g of Bacto Tryptone, 5 g of Bacto Yeast Extract, and 10 g of NaCl per liter, pH 7) was used to grow all bacterial cultures unless specifically indicated. The antibiotics streptomycin (100 p,g/ml), ampicillin (35 ,ug/ml for N43 and 100 ,ug/ml for other strains), and kanamycin (35 ,ug/ml) were used for selection.
Plasmids and phages. Kohara X phage clones KiSO, K1Sl, and K530 were kindly provided by Fred Blattner (University of Wiscortsin). KlSO and K1S1 span the 10.5-min region of the E. coli chromosome (17, 26, 39) , and K530 has been previously mapped by hybridization to contain envCD (15) . To isolate acrA, KlSO and K1S1 were subcloned into either pUC19 or pBR322 to generate plasmids pUCK1SOA, pBRK1SOB, pUCKlSlA, pBRK1S1B, and pUCKlSlC ( Fig.  1) . Plasmids pUCK1SOA and pBRK1SOB contained fragments from KlSO. Plasmids pUCKlSlA, pBRK1SlB, and pUCK151C contained fragments from K1S1. Plasmid pHA contained a 1.8-kb BglII-to-EcoRV fragment from K151 cloned into pUC19, and pLA contained a 1.6-kb BglII-toNaeI fragment covering most of the same region from K1S1 cloned into pACYC177.
Complementation analysis. The inhibitory concentrations for growth in the presence of novobiocin and mitomycin C were determined on LB plates for strains W4573 and N43. For W4573, no growth inhibition was observed at 30 ,ug/ml for novobiocin and 1 ,ug/ml for mitomycin C. For N43, inhibition occurred at S and 0.1 ,g/ml, respectively. Plasmids containing subclones of K150 and K151 were transformed into N43 and selected for ampicillin resistance. Transformants were then restreaked onto plates containing either 30 ,g of novobiocin per ml or 0.3 ,ug of mitomycin C per ml. Complementation was scored after overnight growth on plates at 37°C. DNA sequencing. Sequencing was performed by using the nucleotide kit for sequencing with Sequenase T7 DNA polymerase and 7-deaza-dGTP (catalog no. 70750; United States Biochemical).
PCR amplifications. Genomic DNA from N43 was purified as described by Sambrook et al. (40) . The polymerase chain reaction (PCR) was performed in a total volume of 100 ,ul containing 3 ng of genomic DNA, 1 ,uM forward and reverse primers, 50 mM KCl, 10 mM Tris-HCI (pH 8.3), 1.5 mM MgCl2, 0.001% gelatin, 10% glycerol, 200 ,M (each) of the four deoxynucleoside triphosphates, and 5 U of Taq DNA polymerase (Perkin Elmer-Cetus). The reactions were carried out for 30 cycles with the following temperature profile: 94°C for 1 min, 45°C for 1 min, and 72°C for 2 min.
Construction of TnphoA fusions. XTnphoA-1 was used for the purpose of inserting TnphoA into multicopy plasmid pHA. All other procedures were as described by Manoil and Beckwith (22) .
Alkaline phosphatase activity assays. Alkaline phosphatase activity was assayed according to a standard protocol. A 1-ml aliquot of cells was removed from the culture at an optical density at 600 nm (OD6. After cell debris was spun down, the A420 was recorded and corrected for residual scattering at 550 nm. Cell scattering on the original samples at 600 nm was also measured, and phosphatase activity was calculated from the following formula: PhoA activity = Nucleotide sequence accession number. The GenBank accession number for acrA and acrE is U00734.
RESULTS
Cloning of the acrA locus by complementation. The acrA locus is situated between 10 and 11 min on the genetic map of E. coli (31) . Two isolates from the Kohara bacteriophage X library, K150 (19B7) and K151 (8C4), span this region (26, 39) . Five DNA fragments ranging from 5.5 to 10 kb were subcloned from K150 and K151 into high-copy-number vectors to test for complementation of the acrAl allele in strain N43. As judged from previous reports (3) and our data (see below), N43 is susceptible to mitomycin C at 0.1 1Lg/ml and novobiocin at 5 ,g/ml, whereas its isogenic parent W4573 (acrA+) is resistant to mitomycin C at 1 ,g/ml and novobiocin at 30 ,g/ml. Therefore, N43 transformed by these plasmid constructs was tested for its ability to grow on LB agar plates containing mitomycin C at 0.3 pg/ml or novobiocin at 30 ,ug/ml. As shown in Fig. 1 , two of the five DNAs, a 6.5-kb BglII-BglII fragment (pUCKiSlA) and a 7.4-kb EcoRV-HindIII fragment (pBRK151B), both from K151, supported growth of N43 in the presence of otherwise inhibitory concentrations of mitomycin C and novobiocin. A plasmid containing DNA common to these two constructs, the 1.8-kb BglII-EcoRV fragment of pHA, also rescued the drug susceptibility of N43. These results suggest either that the drug resistance determinant of acrA resides within this 1.8-kb region or that overexpression of this region on a high-copy-number plasmid can suppress the phenotype of an acrA mutant. To confirm that the drug resistance supplied by plasmid pHA was caused by complementation of acrA and not by suppression, we cloned a 1.6-kb BglII-NaeI fragment, which contained all but 200 bp of the insert from pHA, into the low-copy-number vector pACYC177 (Fig. 1) . The resulting construct, designated pIA, was still able to complement the drug susceptibility of N43, suggesting that acrA was indeed encoded by this DNA fragment.
Sequence analysis of the acrA locus. The 1.8-kb BglIIEcoRV fragment from pHA was sequenced (nucleotides 3 to 1847; Fig. 2 ). It contained one intact upstream ORF and one incomplete downstream ORF arranged in parallel orientation. Since this 1.8-kb fragment alone was sufficient to complement the drug-susceptible phenotype of the acrA mutant N43, we named the upstream gene acrA. This designation is consistent with the subsequent analysis of the site of mutation in strain N43. The acrA gene product is predicted to contain 397 amino acids with a molecular weight of 42,000. The first 24 amino acids of AcrA show features typical of a prokaryotic lipoprotein signal peptide, including two positively charged residues (Lys and Arg) near the N terminus, a central hydrophobic domain (Phe-Thr-Pro-LeuAla-Val-Val-Leu-Met-Leu), and a C-terminal region which contains the consensus processing site for prelipoprotein precursors (Leu-Thr-Gly-Cys) (10) . Since the downstream ORF is probably also involved in the full drug resistance observed in the parental strain W4573 (see below), we extended our sequencing to encompass this ORF. This second ORF encodes a protein of 1,049 amino acids with a molecular weight of 114,000. We named this gene acrE (acrB, acrC, and acrD have been previously assigned [1] ). A possible rho-independent termination signal was identified about 40 nucleotides downstream of the stop codon of acrE. No transcription termination signal was observed in the intergenic region between acrA and acrE.
Hydropathy plots for AcrA and AcrE are shown in Fig. 3 . Except for the potential N-terminal signal peptide, no transmembrane segment is evident in AcrA. On the other hand, AcrE contains several (about 12) highly hydrophobic regions but no potential signal peptide. It is especially interesting that AcrE contains two large hydrophilic domains (amino acids 50 to 350 and 575 to 875) and that the N-and C-terminal halves of AcrE have symmetrical hydropathy profiles (Fig.  3B) .
Identification of the acrA mutation in N43. We have identified the exact mutation in N43 by PCR amplification and DNA sequencing (Fig. 4) . Unexpectedly, when genomic DNA from N43 was used as the template, the amplified product was about 1.3 kb longer than predicted from our sequence, indicating the existence of insertion at or near the 5' end of acrA ( Fig. 4A and B) . Using various combinations of forward and reverse primers for PCR, we were able to narrow the insertion site down to the region between the primers F3 and R5. Sequencing revealed that an IS2 element was inserted within the second codon of acrA (Fig. 4C) . One consequence of such an insertion would be the absence of the acrA gene product in N43, which by itself might account for the observed drug susceptibility. It is also possible that this IS2 insertion has additional polar effects on downstream genes such as acrE.
The cellular localization of AcrA and AcrE. The TnphoA method of generating fusions to the E. coli phoA gene was originally developed to identify proteins containing membrane translocation or insertion signals (22) . Recently, the same approach has also been applied to study the topology of membrane proteins (23 TTT TGC AAT CTC GCC  CAC ATC GAG GAT GTG  TTC GTG AAT TTA CAG  CGA TAA TAT AAA CGC  GAC ACT CGA GGT TTA   ATG CTC TCA GGC CAG CGA GGT GGA TGA TAC CCC  TTG GCG CGT TTC TTG CGC TTC  GCG TTA GAT TTA CAT ACA TTT  AGC AAT GGG TTT ATT AAC TTT  CAT localizations of AcrA and AcrE by this method. After transferring X::TnphoA to CC118 carrying pHA, we selected blue colonies on plates which contained the phosphatase indicator dye 5-bromo-3-chloroindolyl phosphate. CC118 is an E. coli strain in which the chromosomal phoA gene has been deleted (22) . Selection of TnphoA fusion was carried out according to previously described procedures (22) [16] ). AcrA shared 65% amino acid identity with EnvC. Though AcrE had considerable stretches of similarity with the published EnvD sequence, the N-terminal 68 amino acids of AcrE lacked a comparable region in EnvD. Several discrepancies were also present in other regions. These inconsistencies led us to resequence the regions in question, starting from Kohara phage K530 as a source of DNA. We discovered several errors in the original sequence reported by Klein et al. (15) (Table 2 ). Using the revised envD sequence, we found AcrE and EnvD to be 77% identical (Fig. 5) . These strong homologies imply similar structures and functions for AcrAE and EnvCD. Interestingly, EnvC has been shown to be processed posttranslationally, probably as a result of removal of the N-terminal signal peptide (15) . E. coli PM61, which contains an unidentified mutation in the envCD locus, was also reported to be VOL. 175, 1993 6306 MA ET AL. hypersusceptible to basic dyes, detergents, and antibiotics (16) .
Drug susceptibilities of acrAE and envCD mutants. To understand the roles that AcrAE and EnvCD play in affecting drug susceptibilities, the MICs of various drugs have been determined and compared for both mutants (N43 and PM61) and their corresponding parental strains (W4573 and P678SR) ( Table 3) . We point out here that P678, rather than P678SR, is the isogenic parent of PM61 (12) . P678SR is derived from P678, and they differ in that P678SR carries an additional mutation at the mtl locus. mtl is not known to affect any drug susceptibility in E. coli.
Both mutants show hypersusceptibility to mitomycin C, erythromycin, and fusidic acid (>15-fold). Interestingly, N43 is much more susceptible to ethidium bromide and novobiocin than is PM61. On the other hand, PM61 is far more sensitive to actinomycin D, vancomycin, and penicillin G than is N43.
A model to explain the drug susceptibility of N43 and PM61 is that acrAE and envCD encode two transmembrane drug efflux pumps. This model is tempting since no apparent defect of the outer membrane was reported in N43 or PM61. To test this model, we have studied acriflavine uptake by intact cells in the absence and presence of CCCP. CCCP is a potent inhibitor that dissipates the electrochemical proton gradient. Since drug pumps use either the proton motive force or ATP as an energy source to expel drugs, CCCP will abolish their ability to pump drug molecules against a concentration gradient (19) . If a concentration gradient across the cell membrane has been generated as the result of an energy-dependent pumping process, addition of CCCP will lead to rapid influx of the drug into the cell. As Fig. 6 shows, prior to the addition of CCCP, a higher level of acriflavine (about fourfold) was accumulated in N43 than in the wild type, W4573, in the presence of the same amount of acriflavine. This observation is consistent with the acriflavine-susceptible phenotype of N43. After addition of 100 ,uM CCCP, rapid accumulation of acriflavine was observed in both N43 and W4573. Therefore, both N43 and W4573 possess the ability to expel acriflavine against a concentration gradient. We have also measured the kinetics of acriflavine efflux from N43 and W4573. Cells were loaded with acriflavine in the presence of CCCP. After CCCP was washed from cells, there was a rapid acriflavine efflux from the cells. However, we could not find large differences in efflux rates between the two strains (data not shown). AcrE may also be involved in drug susceptibilities. The genes envC and envD have been shown to be on the same operon, and both gene products are required to complement the drug susceptibility in PM61 (16) . This finding suggests the possibility of a similar situation for acrA and acrE. To test this idea, we repeated the MIC experiments with novobiocin and ethidium bromide by using pLA, pHA, and DISCUSSION A complementation assay has been used to clone the acrA locus, responsible for the drug hypersusceptibility observed in E. coli N43. DNA sequencing revealed two ORFs whose genes have been named acrA and acrE. The acrA locus is the site of an insertion by IS2 in N43, the prototypic acrA mutant strain. Sequence analysis and TnphoA fusion studies suggest that acrA encodes a lipoprotein with most of the mature portion in the periplasm and that acrE may encode a protein with multiple transmembrane segments. The second residue in the mature AcrA polypeptide is predicted to be aspartate (Asp), if processing by signal peptidase II occurs as we have suggested. Yamaguchi et al. (44) have proposed that the second residue on a mature lipoprotein functions as a sorting signal for localization to the outer or inner bacterial membrane. According to this hypothesis, an Asp residue at the second position should direct AcrA to the inner membrane. Determination of whether AcrA is an inner membrane lipoprotein awaits more rigorous studies that include metabolic labeling in the presence and absence of globomycin and subcellular fractionation. Similarly, more detailed studies by using additional TnphoA fusions are required to determine the topology of AcrE unambiguously.
Although we isolated 10 in-frame acrA::TnphoA fusions, we did not obtain any between residues 197 and 370 of AcrA. Active fusion sites were present at both the N-and C-terminal sides of this region, however. This region constitutes about 50% of the length of AcrA, and the hydropathy plot of AcrA does not reveal any obvious transmembrane segments (Fig. 3A and Table 1 ). One possible explanation is that the sequence bias for TnphoA transposition discriminates against insertion between residues 197 and 370. Another possibility is that the enzymatic activity of PhoA fused to this particular region of AcrA is low because of its cellular localization. Future work, such as making the TnphoA fusions within this region by PCR, would clarify this issue.
The sequence similarities between AcrAE and EnvCD are striking and suggest a recent gene duplication event. Most likely, these genes evolved from the same ancestor and subsequently diverged in sequence and function. The hydropathy profile of AcrE predicts a 12-transmembrane polypeptide with a symmetrical hydrophobicity pattern between its N-and C-terminal halves (Fig. 3B) a Derived from the low-copy-number vector pACYC177; contains the insertion sequence which encodes the intact AcrA and the N-terminal 40 amino acid residues of AcrE.
b Derived from the high-copy-number vector pUC19; contains the insertion sequence which encodes the intact AcrA and the N-terminal 101 amino acid residues of AcrE.
c Derived from the high-copy-number vector pUC19; contains the insertion sequence which encodes the intact AcrA and AcrE. levels of acriflavine in Fig. 6 ). The homology among AcrAE, EnvCD, and the carboxyl terminus of a putative ORF, which has been identified and located around 53 min of E. coli genetic map by Bouvier et al. (2) , suggests that they may represent a new family of proteins with similar functions.
Therefore, there may be multiple pumps in E. coli designed in such a way that they have not only different but also overlapping substrates to allow the optimum control of both specificities and capacities. We are currently designing experiments to test models iii and iv.
Despite the observations that some mutations at the acrAE or envCD loci increase drug susceptibilities in E. coli, the exact functions of these genes remain unclear. Both N43 and PM61 display pleiotropic phenotypes even in the absence of drugs, and this finding indicates more general roles for these polypeptides in E. coli. In addition to the drugsusceptible phenotype, N43 is susceptible to high concentrations of sodium ion in the growth medium (32; our unpublished data). The acrA allele has also been shown to interact with the adk gene (formerly pisA, encoding adenylate kinase) (31) . Mutations at the acrA locus seem to enable AtopA mutants to survive under specific growth conditions of low osmolarity (6) . On the other hand, the envCD mutation in PM61 causes susceptibility to phospholipase C (41) and filamentous growth at high temperatures (16) . Some morphological change of the inner membrane was reported in N43 in the presence of acriflavine (30, 33) . A change in phospholipid composition was also observed in PM61 (25) .
How mutations at the acrAE locus help AtopA strains survive is an intriguing question. Liu and Wang have shown that transcription can generate supercoiling (20) because the topology of transcription requires a relative rotation between RNA polymerase and DNA (7) . Using plasmids as a model system, we have shown that the generation of transcriptioninduced supercoiling is very inefficient during transcription of cytosolic genes (4). On the other hand, transcription of membrane genes, particularly those encoding integral inner membrane proteins like tet, can lead to the rapid accumulation of negative supercoils on the DNA template under AtopA background (4; our unpublished data; also see reference 21). This is probably due to the membrane anchoring of RNA polymerase through the coupling of transcription, translation, and membrane insertion of the nascent polypeptides. Presumably, expression of some chromosomal genes encoding integral membrane proteins is deleterious in AtopA strains because of the high level of localized negative supercoiling which could result. VOL. 175, 1993 One potential mechanism to help AtopA strains would be that mutation at the acrAE loci relieves the transcriptioninduced superhelical stress by decreasing the coupling efficiency between transcription, translation, and membrane insertion. It has been observed that an envCD mutant displays a phenomenon known as delayed tetracycline resistance (14a). It will be interesting to determine whether delayed expression of tetracycline resistance in PM61 is caused by the inefficient membrane insertion of the tet gene product. Other alternative possibilities would be that mutation at the acrAE locus leads to a direct change of chromosomal structure or a lower than normal gyrase activity in vivo.
